Total Payments
$781,382
2024 Payments
$63,770
Companies
37
Transactions
1,623
Medicare Patients
4,095
Medicare Billing
$635,802
Payment Breakdown by Category
Other$625,785 (80.1%)
Travel$91,927 (11.8%)
Food & Beverage$32,478 (4.2%)
Consulting$31,077 (4.0%)
Education$117.29 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $606,941 | 321 | 77.7% |
| Travel and Lodging | $91,927 | 249 | 11.8% |
| Food and Beverage | $32,478 | 1,014 | 4.2% |
| Consulting Fee | $31,077 | 15 | 4.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $12,238 | 10 | 1.6% |
| Compensation for serving as faculty or as a speaker for a medical education program | $6,606 | 6 | 0.8% |
| Education | $117.29 | 8 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $368,969 | 524 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $98,007 | 163 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $83,493 | 117 | $0 (2021) |
| Abbott Laboratories | $48,102 | 155 | $0 (2024) |
| ABBVIE INC. | $31,614 | 76 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $29,690 | 63 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $29,345 | 73 | $0 (2024) |
| Corcept Therapeutics | $28,897 | 37 | $0 (2024) |
| Mannkind Corporation | $22,600 | 113 | $0 (2024) |
| Lilly USA, LLC | $17,288 | 78 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $63,770 | 152 | Novo Nordisk Inc ($36,186) |
| 2023 | $43,934 | 121 | Novo Nordisk Inc ($29,479) |
| 2022 | $94,792 | 182 | Novo Nordisk Inc ($78,373) |
| 2021 | $116,496 | 209 | Novo Nordisk Inc ($77,544) |
| 2020 | $67,585 | 199 | Novo Nordisk Inc ($43,901) |
| 2019 | $112,871 | 250 | Novo Nordisk Inc ($31,572) |
| 2018 | $167,391 | 269 | Novo Nordisk Inc ($69,004) |
| 2017 | $114,544 | 241 | AstraZeneca Pharmaceuticals LP ($53,298) |
All Payment Transactions
1,623 individual payment records from CMS Open Payments — Page 1 of 65
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.70 | General |
| Category: Diabetes | ||||||
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.39 | General |
| Category: Diabetes | ||||||
| 12/16/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $29.43 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: Diabetes Care | ||||||
| 12/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,537.50 | General |
| Category: Diabetes Care | ||||||
| 12/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Travel and Lodging | In-kind items and services | $1,196.16 | General |
| Category: Diabetes Care | ||||||
| 12/09/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: Diabetes Care | ||||||
| 12/06/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $5.99 | General |
| Category: Durable Pump | ||||||
| 12/04/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/04/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $8.37 | General |
| 11/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Travel and Lodging | In-kind items and services | $1,420.44 | General |
| Category: Diabetes Care | ||||||
| 11/21/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $17.15 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 11/21/2024 | Medtronic, Inc. | INPEN SMART INSULIN DELIVERY SYSTEM (Device) | Food and Beverage | In-kind items and services | $8.17 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 11/21/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $4.44 | General |
| Category: Diabetes Care | ||||||
| 11/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,537.50 | General |
| Category: Diabetes Care | ||||||
| 11/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,537.50 | General |
| Category: Diabetes Care | ||||||
| 11/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| Category: Diabetes Care | ||||||
| 11/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Travel and Lodging | In-kind items and services | $16.41 | General |
| Category: Diabetes Care | ||||||
| 11/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $10.05 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $61.02 | General |
| Category: Durable Pump | ||||||
| 11/14/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $60.34 | General |
| Category: Durable Pump | ||||||
| 11/14/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $55.96 | General |
| Category: Durable Pump | ||||||
| 11/14/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $2.66 | General |
| Category: Durable Pump | ||||||
| 11/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Travel and Lodging | In-kind items and services | $1,158.78 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 764 | 1,447 | $228,700 | $107,368 |
| 2022 | 10 | 905 | 1,718 | $278,205 | $134,216 |
| 2021 | 12 | 1,138 | 2,463 | $420,025 | $209,057 |
| 2020 | 13 | 1,288 | 2,502 | $356,895 | $185,161 |
Total Patients
4,095
Total Services
8,130
Medicare Billing
$635,802
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 339 | 702 | $140,650 | $70,731 | 50.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 99 | 120 | $24,000 | $11,815 | 49.2% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 176 | 372 | $27,900 | $10,270 | 36.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 33 | 33 | $13,200 | $5,219 | 39.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 30 | 32 | $8,800 | $4,646 | 52.8% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2023 | 19 | 19 | $6,650 | $2,292 | 34.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 86 | $4,300 | $929.55 | 21.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 12 | $1,900 | $857.85 | 45.2% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 19 | 21 | $1,050 | $547.26 | 52.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 14 | 50 | $250.00 | $60.71 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 397 | 820 | $164,000 | $83,671 | 51.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 150 | 200 | $40,000 | $21,010 | 52.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 179 | 449 | $33,675 | $12,752 | 37.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 27 | 27 | $10,800 | $4,795 | 44.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 66 | $9,900 | $4,173 | 42.2% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2022 | 19 | 23 | $8,050 | $2,986 | 37.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 16 | $4,400 | $2,223 | 50.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 24 | 27 | $4,050 | $1,820 | 44.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 25 | 64 | $3,200 | $750.62 | 23.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 12 | 26 | $130.00 | $34.27 | 26.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 496 | 1,290 | $258,000 | $136,400 | 52.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 158 | 237 | $45,600 | $24,478 | 53.7% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 179 | 574 | $43,050 | $16,869 | 39.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 46 | 46 | $18,400 | $8,218 | 44.7% |
| 95250 | Ambulatory continuous glucose (sugar) monitoring for a minimum of 72 hours | Office | 2021 | 43 | 47 | $16,450 | $6,327 | 38.5% |
About Jaiwant Rangi, MD, FACE
Jaiwant Rangi, MD, FACE is a Endocrinology, Diabetes & Metabolism healthcare provider based in Folsom, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902878978.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jaiwant Rangi, MD, FACE has received a total of $781,382 in payments from pharmaceutical and medical device companies, with $63,770 received in 2024. These payments were reported across 1,623 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($606,941).
As a Medicare-enrolled provider, Rangi has provided services to 4,095 Medicare beneficiaries, totaling 8,130 services with total Medicare billing of $635,802. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Internal Medicine
- Location Folsom, CA
- Active Since 02/03/2006
- Last Updated 11/21/2018
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1902878978
Products in Payments
- Ozempic (Drug) $147,672
- RYBELSUS (Drug) $77,092
- FARXIGA (Drug) $64,784
- SOLIQUA (Drug) $48,231
- Wegovy (Drug) $38,820
- TOUJEO (Drug) $38,403
- JARDIANCE (Drug) $36,856
- Rybelsus (Drug) $32,548
- STEGLATRO (Drug) $29,567
- Korlym (Drug) $28,897
- Synthroid (Drug) $28,570
- FreeStyle Libre Pro (Device) $26,094
- Saxenda (Drug) $25,080
- Tresiba (Drug) $24,182
- AFREZZA (Drug) $22,600
- FREESTYLE LIBRE 3 (Device) $20,257
- BYDUREON (Drug) $18,324
- Kerendia (Drug) $10,984
- SOLIQUA 100/33 (Drug) $9,212
- ZEPBOUND (Drug) $8,493
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.